Vanderbilt University Medical Center: Supercomputing Redesign of a COVID Monoclonal Antibody
May 10, 2024
May 10, 2024
NASHVILLE, Tennessee, May 10 (TNSres) -- Vanderbilt University Medical Center issued the following news release:
* * *
The approach, which combines high-performance computing, simulation, machine learning and experimental validation, will help keep antibody drugs up to date in the future against highly variable viruses.
* * *
One of the monoclonal antibodies in the therapeutic Evusheld has been computationally redesigned to restore its action a . . .
* * *
The approach, which combines high-performance computing, simulation, machine learning and experimental validation, will help keep antibody drugs up to date in the future against highly variable viruses.
* * *
One of the monoclonal antibodies in the therapeutic Evusheld has been computationally redesigned to restore its action a . . .